Nuheara Enters Global Agreement with HP to Develop, Manufacture and Market Hearing Aid Products Under HP Brand

PERTH, AUSTRALIA — Medical device and consumer electronics manufacturer, Nuheara Limited (ASX:NUH) has announced that it has further strengthened its partnership with HP Inc. (HP) through entering into a worldwide Trademark License Agreement for use of certain HP trademarks on Nuheara’s hearing aids, personal sound amplification devices and accessories. The Agreement grants Nuheara a license…

Read More
nuheara oto tinnitus

Nuheara and Oto Announce Global Collaboration for Tinnitus Support 

PERTH, AUSTRALIA — Australian hearing health company, Nuheara (ASX:NUH) and Oto, the UK based digital health company for tinnitus support, have announced “the world’s first collaboration to provide digital-led, tech-enabled support for people affected by tinnitus”. The collaboration brings together Nuheara’s award-winning ​​IQbuds² MAX hearing buds, which enable users to personalize and augment their hearing using smartphones and tablets, with…

Read More
nuheara

Nuheara Announces $7.6M Capital Raise to Support Growth

PERTH, AUSTRALIA — Nuheara Limited (ASX:NUH) has announced a Capital Raising comprising: $3.0 million to be invested by United States-based Healthcare 2030, LLC; $1.6 million private placement commitments from existing and new professional sophisticated investors; and A Share Purchase Plan aiming to raise up to $3.0 million (with Board discretion to accept oversubscriptions) to provide…

Read More
nuheara sonova

Nuheara Secures Global Supply Agreement with Sonova

PERTH, AUSTRALIA — Nuheara Limited (ASX:NUH) has announced that the company has secured a three year Global Supply Agreement with Phonak parent company, Sonova AG. Under the agreement, the company will supply Nuheara-manufactured and branded products to Sonova and its affiliates worldwide.  Headquartered in Stäfa Switzerland, Sonova is a leading global supplier of innovative hearing…

Read More
nuheara iqbuds2 pro fda registration

Nuheara Partners with NAL to Commence Medical Device Trial

Nuheara has announced that it will commence a clinical trial to test the safety and effectiveness of Nuheara’s newly developed range of hearing aid products, to support Nuheara’s planned expansion into clinically tested and regulatory approved medical devices. Nuheara has engaged National Acoustics Laboratories (NAL) under the terms of a Clinical Trial Agreement (CTA) to assist…

Read More
nuheara iqbuds2 pro fda registration

Nuheara Announces Senior Leadership Appointments

SAN FRANCISCO, CALIFORNIA — With mild-to-moderate hearing loss on the rise, and the Over-the-Counter (OTC) Hearing Aid Act soon to be implemented, Nuheara (ASX:NUH) today announced a string of senior hearing-health sector appointments to strengthen its market position. The augmented hearables pioneer is “at the forefront of bringing affordable and accessible hearing solutions to the mass market with its…

Read More
nuheara iqbuds2 pro fda registration

Nuheara Appoints John Luna as Global Business Development Manager

Nuheara Limited has announced the appointment of hearing industry veteran, John R. Luna, as Global Business Development Manager, effective immediately. Based in the United States, Mr. Luna has spent most of his career in senior management and executive leadership positions, specializing in business development, sales and commercialization of medical device and hearing healthcare products. Over…

Read More
nuheara iqbuds2 pro fda registration

Nuheara Receives FDA Registration and Medical Device Listing for IQbuds² PRO Hearing Aid

PERTH, AUSTRALIA — Nuheara Limited (ASX: NUH) has announced that the company has received U.S. Food and Drug Administration (FDA) establishment registration for a medical device listing of a new hearing aid, IQbuds² PRO (PRO). The PRO, alongside IQbuds² MAX (MAX), will be second product to be derived from the recently developed IQbuds² hardware platform.…

Read More
nuheara

Nuheara Signs 3 Year Manufacture and Supply Agreement With HP; Raises $11.5M to Accelerate Company Growth

PERTH, AUSTRALIA — Nuheara Limited (ASX: NUH) has announced that it has received binding commitments to raise $11.5 million before costs through an oversubscribed placement of 287.5 million new fully paid ordinary shares sat an issue price of $0.04 per share. The company’s record sales and collections through the current financial year, supported by the…

Read More